Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Mathurin P et al 2002 France | Individual data of patients with severe Alcoholic hepatitis with discriminant function (DF)> or =32 were collected from the three principal investigators. 102 placebo and 113 corticosteroid patients (prednisolone 40mg/day) with Discrimination factor (DF) > or =32 were analyzed. | Data analysis of the three randomized placebo controlled double blind trials | Short term survival in patients with severe alcoholic hepatitis receiving corticosteroids | At 28 days, corticosteroid patients had significantly higher survival: 84.6+/-3.4% vs. 65.1+/-4.8%, P=0.001. | |
Cabre E et al 2000 spain | A total of 71 patients (80% cirrhotic) were randomized to receive 40 mg/d prednisolone (n = 36) or enteral tube feeding (2,000 kcal/d) for 28 days (n = 35), and were followed for 1 year or until death. | Multicenter randomized trial. Level 1 b | Short term effects of total enteral nutrition or steroids in patients with alcoholic hepatitis | enteral feeding(69%) does not seem to be worse than steroids(75%) in the short-term treatment of severe alcohol-induced hepatitis | |
Mortality in patients treated by total enteral nutrition or steroidis in patients with alcoholic hepatitis | Mortality during treatment was similar in both groups (9 of 36 vs. 11 of 35, intention-to-treat) but occurred earlier with enteral feeding (median 7 vs. 23 days; P =.025). Mortality during follow-up was higher with steroids (10 of 27 vs. 2 of 24 intention-to-treat; P =. 04). | ||||
Ramond MJ et al 1992 France | Randomised, double-blind trial comparing 28 days of prednisolone treatment (40 mg per day) with placebo in 61 patients with biopsy-proved alcoholic hepatitis and either spontaneous hepatic encephalopathy (n = 19) or a discriminant-function value higher than 32. The discriminant function used was as follows: 4.6 (prothrombin time-control time [in seconds]) + serum bilirubin (in micromoles per liter)/17. | Randomised double-blind trial | Short term survival of patients with alcohol hepatitis on steroids | By the 66th day after randomization, 16 of 29 placebo recipients had died (mean [+/- SE] survival, 45 +/- 8 percent), as compared with 4 of 32 prednisolone recipients (survival, 88 +/- 5 percent) (log-rank test, 10.9; P = 0.001). | |
Imperiale TF et al 1990 USA | 11 randomised studies (10 of which were placebo controlled) that assessed mortality in hospitalized patients diagnosed with acute alcoholic hepatitis and treated with corticosteroids | Meta-analysis of randomised trials | The protective efficacy (or percent reduction in mortality) | The protective efficacy of corticosteroids was 37% (95% CI, 20% to 50%). |